Paul D Hale

Title: Paul D Hale - Innovator in Platelet Reactivity Assessment

Introduction

Paul D Hale is a notable inventor based in Burlington, Vermont, who has made significant contributions to the field of medical technology. He holds a patent that focuses on the assessment of platelet reactivity in whole blood samples, which is crucial for monitoring antiplatelet pharmacologic agents.

Latest Patents

Hale's patent, titled "Method for determining platelet reactivity in a whole blood sample," provides a novel approach for quantifying and assessing platelet activation. This method involves exposing platelets to a physiological concentration of an agonist, leading to the formation of binding sites on the surface of activated platelets. The ability to measure these activated platelets allows for a better understanding of specific components of platelet activation.

Career Highlights

Paul D Hale is associated with Lionheart Technologies, Inc., where he applies his expertise in medical technology. His work has been instrumental in advancing methods for evaluating platelet function, which is vital for patients undergoing antiplatelet therapy.

Collaborations

Throughout his career, Hale has collaborated with esteemed colleagues such as David Schneider and Burton E Sobel. These partnerships have contributed to the development of innovative solutions in the medical field, particularly in the area of platelet reactivity.

Conclusion

Paul D Hale's contributions to the assessment of platelet reactivity highlight his role as an innovator